Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Stakeholders weigh in on potential reforms to FDA advisory committee process
11 months ago
Pharma
FDA+
Pharma industry praises Supreme Court's rejection of abortion pill challenge
11 months ago
Pharma
FDA+
Telehealth startup Done's execs arrested and charged for alleged Adderall scheme, DOJ says
11 months ago
Startups
Pharma
Alchem faces fines over price-fixing allegation from the European Commission
11 months ago
Pharma
Manufacturing
Radiopharma execs warn that lutetium could be at risk of shortage
11 months ago
Manufacturing
Siegfried nabs US site from Curia; Merck KGaA pumps €62M more into its headquarters
11 months ago
Manufacturing
Ultragenyx to seek accelerated approval for rare disease gene therapy
11 months ago
Cell/Gene Tx
FDA+
UroGen touts long duration of response for its bladder cancer chemotherapy gel
11 months ago
R&D
J&J returns bispecific T cell engager to Xencor, reducing scope of partnership
11 months ago
Deals
R&D
Avidity’s $300M offering; Rapport raises $174M
11 months ago
News Briefing
Is $13B Devoted Health succeeding where other insurance upstarts have failed?
11 months ago
Startups
Health Tech
AbbVie banks on second-gen TL1A program, licensing antibody from FutureGen
11 months ago
Deals
'Speed is everything': Versant-backed immunology startup raises $125M with plans for quick data
11 months ago
Financing
Startups
Surprise flop for Cara’s oral pruritus drug forces company to cut its last R&D program
11 months ago
R&D
Barinthus Bio to lay off 25% of its workforce and focus on just two programs
11 months ago
People
R&D
Exclusive: Former Merck scientists raise $85M to map and drug protein interactions in cancer and autoimmune disease
11 months ago
Financing
Startups
Only a third of employers and health plans cover GLP-1 drugs for weight loss, report says
11 months ago
Pharma
Health Tech
Pfizer’s Duchenne muscular dystrophy gene therapy fails Phase 3 trial
11 months ago
R&D
Cell/Gene Tx
Gilead's M&A appetite is for deals in the 'mid-single-digit billions,' CEO says
11 months ago
Deals
Pharma
Lilly, Eisai and Biogen seek more specifics in FDA guidance on early Alzheimer’s disease
11 months ago
Pharma
FDA+
States join Oklahoma effort to convince Supreme Court to let them regulate PBMs
11 months ago
Pharma
Law
Pfizer strikes an R&D partnership with Flagship's ProFound as it looks for next-gen obesity assets
11 months ago
Deals
R&D
J&J agrees to $700M talc settlement with 42 states and DC
11 months ago
Pharma
Law
Alzheon raises $100M; Regeneron ends mid-stage trial
11 months ago
News Briefing
First page
Previous page
143
144
145
146
147
148
149
Next page
Last page